Cargando…
SAT-130 The Intermediate Prolactin Receptor Is a Breast Cancer Oncogene
Epidemiological, cellular, and genetic analyses indicate the hormone prolactin (PRL) and its cognate receptor in humans (hPRLr) are significantly involved in breast cancer pathogenesis. Recent evidence demonstrated that a truncated mouse PRLr (mPRLrT) is oncogenic when expressed with canonical long...
Autores principales: | Grible, Jacqueline M, Zot, Patricija, Harrell, J Chuck, Idowu, Michael, Clevenger, Charles V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207700/ http://dx.doi.org/10.1210/jendso/bvaa046.1033 |
Ejemplares similares
-
SAT-139 STAT5A Regulation by Serine Phosphorylation in Breast Cancer
por: Woock, Alicia E, et al.
Publicado: (2020) -
The human intermediate prolactin receptor is a mammary proto-oncogene
por: Grible, Jacqueline M., et al.
Publicado: (2021) -
SAT635 Role Of The Human Prolactin Receptor I-tail In The Pathogenesis Of Breast Cancer
por: Clevenger, Charles V, et al.
Publicado: (2023) -
Serine residues 726 and 780 have nonredundant roles regulating STAT5a activity in luminal breast cancer
por: Woock, Alicia E., et al.
Publicado: (2021) -
OR05-02 The IGFBP-3/IGFBP-3 Receptor Axis Is a New Therapeutic Target for Triple Negative Breast Cancer
por: Cai, Qing, et al.
Publicado: (2020)